Pricing updated 2016-02-12. Prices are subject to change without notice.
AH 6809 is an EP and DP receptor antagonist with nearly equal affinity for the cloned human EP1, EP2, EP3-
|Formulation||A crystalline solid|
|λmax||244, 305 nm|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Separate multiple batch numbers with commas
1. Abramovitz, M., Adam, M., Boie, Y., et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483 285-293 (2000).
Woodward, D.F., Pepperl, D.J., Burkey, T.H., et al. 6-
3. Funk, C.D., Furci, L., Fitzgerald, G.A., et al. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 268 26767-26772 (1993).
4. Coleman, R.A., Kennedy, I., and Sheldrick, R.L.G. AH6809, a prostanoid EP1 receptor blocking drug. Br J Pharmacol 85 273P (1985).
5. Kiriyama, M., Ushikubi, F., Kobayashi, T., et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 122 217-224 (1997).
Keery, R.J., and Lumley, P. AH6809, a prostaglandin DP-
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: